2CL Intrinsic Valuation and Fundamental Analysis - BridgeBio Pharma Inc

B	BridgeBio Pharma Inc XBER:2CL	US
	Novonix Ltd ASX:NVX	AU
A	AGC Inc DUS:SHJ	JP
	Namura Shipbuilding Co Ltd OTC:NMRSF	JP
S	Sedlmayr Grund und Immobilien AG XMUN:SPB	DE

Intrinsic Value

2CL price has not been updated for more than 7 years. This may indicate that the stock has been delisted.

The intrinsic value for BridgeBio Pharma Inc (2CL) under the Base Case is hidden EUR. Compared with the current market price of 0.057 EUR, the stock appears hidden .

DCF Value

Locked

Multiples-Based Value

Locked

DCF Value

Locked

Multiples-Based Value

Locked

Why combine DCF with multiples? What is Intrinsic Value?

2CL Intrinsic Value

Unlock

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price €0.06

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

2CL looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 2CL usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for BridgeBio Pharma Inc.

Explain Valuation